文献速递脊柱脊髓外科神经肿瘤

原发与转移性脊柱肿瘤治疗研究注册现状:2000至2020年范围综述

Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020.
PubMed 文献 · Neuro Oncol · 2022-01-01

69项已完成研究中44项结果已发表,试验明显偏向转移瘤而原发肿瘤研究不足。

要点

  • 注册研究以北美单中心干预性研究为主,治疗策略占90.2%。
  • 立体定向放射外科、放疗、化疗和手术技术是主要研究焦点。
  • 研究明显偏向转移性脊柱肿瘤,原发肿瘤研究不足。

核心结论

  • 2000至2020年注册的174项脊柱肿瘤临床研究以转移性肿瘤为主,原发肿瘤研究明显不足。

主要发现

  • 174项注册研究中,101项由北美单中心主导,43项来自欧洲,24项来自亚洲,6项来自其他洲。
  • 90.2%的研究聚焦治疗策略,包括立体定向放射外科33项、放疗21项、化疗20项和手术技术11项。
  • 69项已完成研究中,44项结果已发表于文献。
  • 临床试验明显偏向转移性肿瘤人群,原发肿瘤研究较少。

关键数值与推荐

  • 检索词包括「spinal cord tumor」「spinal metastasis」「metastatic spinal cord compression」。

临床怎么用

  • 神经外科医生应关注转移性脊柱肿瘤的立体定向放射外科、放疗、化疗和手术技术等研究证据。
  • 针对原发脊柱肿瘤的前瞻性研究稀缺,临床决策需谨慎参考有限证据。

局限性

  • 仅纳入美国ClinicalTrials.gov注册研究,可能遗漏其他注册平台的试验。
  • 69项已完成研究中仅44项结果发表,存在发表偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The field of spinal oncology has substantially evolved over the past decades. This review synthesizes and appraises what was learned and what will potentially be discovered from the recently completed and ongoing clinical studies related to the treatment of primary and secondary spinal neoplasms. This scoping review included all clinical studies on the treatment of spinal neoplasms registered in the ClinicalTrials.gov website from February 2000 to December 2020. The terms "spinal cord tumor," "spinal metastasis," and "metastatic spinal cord compression" were used. Of the 174 registered clinical studies on primary spinal tumors and spinal metastasis, most of the clinical studies registered in this American registry were interventional studies led by single institutions in North America (n = 101), Europe (n = 43), Asia (n = 24), or other continents (n = 6). The registered clinical studies mainly focused on treatment strategies for spinal neoplasms (90.2%) that included investigating stereotactic radiosurgery (n = 33), radiotherapy (n = 21), chemotherapy (n = 20), and surgical technique (n = 11). Of the 69 completed studies, the results from 44 studies were published in the literature. In conclusion, this review highlights the key features of the 174 clinical studies on spinal neoplasms that were registered from 2000 to 2020. Clinical trials were heavily skewed toward the metastatic population as opposed to the primary tumors which likely reflects the rarity of the latter condition and associated challenges in undertaking prospective clinical studies in this population. This review serves to emphasize the need for a focused approach to enhancing translational research in spinal neoplasms with a particular emphasis on primary tumors.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Furlan JC, Wilson JR, Massicotte EM, et al. Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020. Neuro Oncol. 2022. PMID: 34508647. doi:10.1093/neuonc/noab214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。